Analystreport

LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

ContextLogic Inc. - Class A  (LOGC) 
Last contextlogic inc. - class a earnings: 8/13 08:00 am Check Earnings Report